SLC2A2 and Hypoglycemia: White et al. identified asymptomatic nocturnal hypoglycemia in a cohort of 23 children and adults with GSD I and GLUT-2 deficiency, enabling the reduction or elimination of nocturnal UCCS intake in those patients who did not have asymptomatic nocturnal hypoglycemia [23].